Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Hamlet BioPharma AB (publ) | HAMLETB | Apr 30, 2024 | 2.47 | -0.40 |
Hansa Biopharma | HNSA | Apr 30, 2024 | 28.94 | -0.21 |
Hanza AB | HANZA | Apr 30, 2024 | 57.75 | -1.28 |
Harm Reduction Group | NOHARM | Apr 30, 2024 | 0.12 | -8.75 |
Havsfrun Investment | HAVS | Apr 30, 2024 | 13.55 | +1.50 |
Havsfrun Investment B | HAVB | Apr 30, 2024 | 13.55 | +1.50 |
Haypp Group | HAYPP | Apr 30, 2024 | 86.20 | +2.62 |
Headsent | VIMAB | Apr 30, 2024 | 10.50 | 0.00 |
Heba B | HEBAB | Apr 30, 2024 | 32.55 | -0.15 |
Hedera Group | HEGR | Apr 30, 2024 | 5.85 | 0.00 |
Heimstaden Pref | HEIMPREF | Apr 30, 2024 | 8.52 | 0.00 |
Heliospectra | HELIO | Apr 30, 2024 | 0.43 | -2.27 |
Hemnet Group | HEM | Apr 30, 2024 | 289.00 | -0.55 |
Hemply Balance | HMPLY | Apr 30, 2024 | 0.04 | +2.86 |
Hexagon B | HEXAB | Apr 30, 2024 | 116.75 | -3.11 |
Hexagon Purus | HPURO | Apr 30, 2024 | 5.35 | +0.75 |
Hexatronic Group | HTRO | Apr 30, 2024 | 34.45 | +2.68 |
Hexicon | HEXI | Apr 30, 2024 | 0.60 | -0.17 |
Hexpol B | HPOLB | Apr 30, 2024 | 126.00 | +0.32 |
Hifab B | HIFAB | Apr 30, 2024 | 2.88 | +3.60 |
High Coast Distillery B | HIGHCOB | Apr 30, 2024 | 46.00 | 0.00 |
Hilbert | HILBB | Apr 30, 2024 | 3.79 | +0.26 |
HMS Networks | HMS | Apr 30, 2024 | 413.60 | -1.34 |
Hoegh Autoliners ASA | HAUTOO | Apr 30, 2024 | 117.20 | +14.45 |
Hoi Publishing AB | HOIB | Apr 30, 2024 | 0.38 | -7.32 |
Hoist Finance | HOFI | Apr 30, 2024 | 52.60 | +0.77 |
Holmen A | HOLMA | Apr 30, 2024 | 427.00 | +1.43 |
Holmen B | HOLMB | Apr 30, 2024 | 431.60 | +1.55 |
HomeMaid B | HOMEB | Apr 30, 2024 | 14.70 | 0.00 |
Hoodin | HOODIN | Apr 30, 2024 | 0.34 | +8.97 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.